2468 Organometallics, Vol. 19, No. 13, 2000
Lanza et al.
3
151.0-124.0 (29C, ArC and pyrC); 60.3 (2C, NCHPh); 21.8 (1C,
CH3); 21.6 (1C, CH3). 31P{1H} NMR (121.49 MHz, CDCl3, 298
K): 13.5 (1J Pt-P ) 3307, Pt-P). Anal (%) Calcd for C35H34N3-
PS2Cl2Pt: C, 49.01; H, 4.00; N, 4.90; S, 7.48; Cl, 8.27. Found:
C, 49.13; H, 4.10; N, 5.12; S, 7.32; Cl, 8.05.
13.8, J H-H ) 6.8, 2H, NCH2 trans to P, part AB of ABC3);
3 3
1.15 (t, J H-H ) J H-H ) 6.8, 3H, CH3 trans to P, part C3 of
ABC3); 0.95, (t, J H-H ) 3J H-H ) 6.8, 3H, CH3 cis to P, part C3
3
of ABC3); 5.42 (m, 1H, central-allyl, CH); 3.52 (m, 3J H-H ) 6.9,
1H, syn-allyl CHH); 3.50 (m, 3J H-H ) 6.9, 1H, syn-allyl CHH);
2.91 (m,3J H-H ) 12.7, 1H, anti-allyl CHH); 2.89, (m, J H-H
)
3
Gen er a l P r oced u r e for th e P r ep a r a tion of Dith ioxa -
m id a to Com p lexes [(P N)ClP t(HR2N2S2C2)] (R ) Eth yl, 4;
R ) Ben zyl, 5; R ) {S}-P h en yleth yl, 6). A 200 mg sample
of sodium bicarbonate was added to 1 mmol of the above ion
pairs dissolved in the minimum amount of chloroform (∼20
mL). The magenta solution immediately turned to orange;
after 0.5 h of stirring, the sodium bicarbonate was removed
by filtration and the orange solution was concentrated to a
small volume (∼1 mL). [(PN)ClPt(HR2N2C2S2)] complexes 4-6
precipitated as orange powders, which were collected and air-
dried. Yields were higher than 90%.
12.7, 1H, anti-allyl CHH). 13C{1H} NMR (75.47 MHz, CDCl3,
3
298 K): 190.8 (d, J C-P ) 11, 1C, CS trans to P); CS 190.3 (d,
3J C-P ) 2, 1C, CS cis to P); 154.6 -124.3 (17C, ArC and pyrC);
115.5 (1C, central-allyl CH); 58.0 (1C, allyl CH2); 57.9 (1C, allyl
CH2); 52.8 (1C, NCH2); 52.1 (1C, NCH2); 13.0 (1C, CH3); 12.7
(1C, CH3). 31P{1H} NMR (121.49 MHz, CDCl3, 298 K): 17.3
(1J Pt-P ) 3267, Pt-P). Anal (%) Calcd for C26H29N3PS2-
ClPdPt: C, 38.33, H, 3.59; N, 5.16; S, 7.83; Cl, 4.30. Found:
C, 38.61; H, 3.71; N, 5.25; S, 8.05; Cl, 4.52.
[(P N)ClP t (µ-N,N′-(C7H 7)2N2S2C2K-S,S′-P t K-N,N′-P d )-
(η3-a llyl)P d ] (8). 1H NMR (300.13 MHz, CDCl3, 298 K): 8.76
(m, 1H, pyrH-6); 8.55 (m, 1H, pyrH-3); 7.60-7.00 (m, 22 H,
ArH and pyrH); 5.10 (AB q,1J ) 15, 2H, NCH2 cis to P); 4.55
(AB q, 1J ) 15, 2H, NCH2 trans to P); 4.90 (m, 1H, central-
[(P N)ClP t(H(C2H5)2N2S2C2)] (4). 1H NMR (300.13 MHz,
CDCl3, 298 K): 8.74 (m, 1H, pyr H-6) 8.39 (m, 1H, pyrH-3);
3
7.87-7.27 (m, 12H, ArH and pyrH); 3.71 (q, J H-H ) 7.3, 2H,
3
3
NCH2) 3.28 (q, J H-H ) 7.3, 2H, NCH2); 1.34 (t, J H-H ) 7.3,
3H, CH3); 1.17 (t, J H-H ) 7.3, 3H, CH3). 13C{1H} NMR (75.47
allyl CH); 3.10 (m, J H-H ) 5.8, 1H, syn-allyl CH H trans to
3
3
3
3
MHz, CDCl3, 298 K): 186.8 (d, J C-P ) 3, 1C); 172.9 (d, J C-P
) 11, 1C, CS trans to P); 150.5-124.9 (17C, ArC and pyrC);
45.3 (1C, NCH2); 41.8 (1C, NCH2); 14.5 (1C, CH3); 13.1 (1C,
CH3). 31P{1H} NMR (121.49 MHz, CDCl3, 298 K): 16.6 (1J Pt-P
) 3408, Pt-P). Anal(%) Calcd for C23H25N3PS2ClPt: C, 41.29;
H, 3.77; N, 6.28; S, 9.58; Cl, 5.30. Found: C, 41.15; H, 3.67;
N, 6.11; S, 9.62; Cl, 5,47.
P); 2.86 (m, 3J H-H ) 5.8, 1H, syn-allyl CH H cis to P); 2.29 (m,
3J H-H ) 12, 1H, anti-allyl CHH cis to P); 2.24 (m,3J H-H ) 12,
1H, anti-allyl CHH trans to P). 13C{1H} NMR (75.47 MHz,
3
CDCl3, 298 K): 192.2 (d, J C-P ) 2, 1C, CS cis to P); 192.1
(d,3J C-P ) 10, 1C, CS trans to P); 150.1-123.0, 29C, ArC and
pyrC); 60.7 (1C, NCH2 cis to P); 60.1 (1C, NCH2 trans to P);
114.7 (1C, central-allyl CH); 59.1 (1C, allyl CH2 cis to P); 58.8
1C, allyl CH2 trans to P). 31P{1H} NMR (121.49 MHz, CDCl3,
[(P N)ClP t(H(C7H7)2N2S2C2)] (5). 1H NMR (300.13 MHz,
CDCl3, 298 K): 8.76 (m, 1H, pyrH-6); 8.39 (m, 1H, pyrH-3);
7.86-7.08 (m, 22H, ArH and pyrH); 4.84 (s, 2H, NCH2); 4.40
(s, 2H, NCH2). 13C{1H} NMR (75.47 MHz, CDCl3, 298 K): 188.0
1
298 K): 17.1 (Pt-P, J Pt-P ) 3272). Anal (%) Calcd for
C36H33N3PS2ClPdPt: C, 46.05; H, 3.55; N, 4.48; S, 6.82; Cl,
3.73. Found: C, 46.16; H, 3.61; N, 4.51; S, 6.70; Cl, 3.57.
[(P N)ClP t(µ-N,N′-({S}-d ip h en yleth yl)d ith ioxa m id a toK-
3
3
(d, J C-P ) 3, 1C, CS cis to P); 185.4 (d, J C-P ) 8, 1C, CS
trans to P); 150.1-124.5 (29 C, ArC and pyrC); 54.5 (1C,
NCH2); 51.0 (1C, NCH2). 31P{1H} NMR (121.49 MHz, CDCl3,
298 K): 16.2 (1J Pt-P ) 3400, Pt-P). Anal (%) Calcd for
S,S′-P t K-N,N′-P d ) (η3-a llyl)P d ] (9). H NMR (300.13 MHz,
1
CDCl3, 298 K): 8.67 (m, 1 H, pyrH-6); 8.46 (m, 1H, pyr H-3);
7.00-7.70 (m, 22 H, ArH and pyrH 9A a n d 9B); 5.85 (q,3J H-H
) 6.6, 0.5H, NCHPh cis to P 9A); 5.81 (q,3J H-H ) 6.6, 0.5H,
NCHPh cis to P 9B); 5.14 (q,3J H-H ) 6.6, 0.5H, NCHPh trans
to P 9A); 5.10 (q, J H-H ) 6.6, 0.5H, NCHPh trans to P 9B);
4.46 (m, 1H, central-allyl CH 9A a n d 9B); 3.15 (m, J H-H
C
33H29N3PS2ClPt: C, 49.97; H, 3.68; N, 5.30; S, 8.08; Cl, 4.47.
Found: C, 50.15; H, 3.76; N, 5.08; S, 8.23; Cl, 4.58.
[(P N)ClP t(H({S}-CHCH3P h )2N2S2C2)] (6). 1H NMR (300.13
MHz, CDCl3, 298 K): 8.74 (m, 1H, pyrH-6); 8.43 (m, 1H, pyrH-
3
3
)
3
3
3); 7.88-7.10(m, 22H, ArH and pyrH); 5.42 (q, J H-H ) 6.6,
6.7, 0.5H, syn-allyl CHH cis to P 9A); 3.06 (m, J H-H ) 6.7,
0.5H, syn-allyl CHH trans to P 9B); 2.49 (m, J H-H ) 6.6, 1H,
1H, NCHPh); 4.74 (q, 3J H-H ) 6.6, 1H, NCHPh); 1.64 (d, 3J H-H
3
) 6.6, 3H, CH3); 1.40 (d, 3J H-H ) 6.6, 3H, CH3). 13C{1H} NMR
syn-allyl CHH overlapped cis to P 9A and trans to P 9B); 2.24
(m, 1H, anti-allyl CHH overlapped trans to P 9B and cis to P
9A); 1.33 (m partially obscured by the methyls, 0.5H, anti-
allyl CHH cis to P 9A); 1.28 (m partially obscured by the
methyls, 0.5H, anti-allyl CHH trans to P 9B); 1.53 (d, 3J )
3
(75.47 MHz, CDCl3, 298 K): 186.5 (d, J C-P ) 3, 1C, CS cis to
3
P); 177,8 (d, J C-P ) 9, 1C, CS trans to P); 149.0-124.3 (29C,
ArC and pyrC); 58.8 (1C, NCHPh); 56.4 (1C, NCHPh); 22.2
(1C, CH3); 20.9 (1C, CH3). 31P{1H} NMR (121.49 MHz, CDCl3,
298 K): 13.5 (1J Pt-P ) 3307, Pt-P). Anal (%) Calcd for C35H33N3-
PS2ClPt: C, 52.12; H, 4.17; N, 5.11; S, 7.80; Cl, 4.31. Found:
C, 51.93; H, 4.20; N, 5.14; S, 7.66; Cl, 4.05.
3
6.6 (1.5H, CH3 cis to P 9A); 1.44 (d, J ) 6.6, 1.5H, CH3 cis to
3
P 9B); 1.33 (d, J H-H ) 6.6, 1.5H, CH3 trans to P 9A); 1.23 (d,
3J H-H ) 6.6, 1.5H, CH3 trans to P 9B). 13C{1H} NMR (75.47
MHz, CDCl3, 298 K): 190.8 (d,3J C-P)10, 0.5C, CS trans to P
Gen er a l P r oced u r e for th e P r ep a r a tion of Bin u clea r
Dith ioxbisa m id a to Com p lexes [(P N)ClP t(µ-R2N2S2C2-K-
S,S-P t-K-N,-P d )P d (η3-C3H5)] (η3-C3H5 ) η3-Allyl; R ) Eth -
yl, 7; R ) Ben zyl, 8; R ) {S}-P h en yleth yl, 9). A 1 mmol
sample of [Pd(η3-C3H5)(µ-Cl)]2 was dissolved in about 30 mL
of a 70:30 v/v chloroform/methanol mixture and reacted with
a half molar quantity of [(PN)ClPt(HR2N2S2C2)] complexes.
The solution, which turned deep red, was allowed to stand for
2 h. The solvents were removed and the crude products,
redissolved in the minimum amount of chloroform (about 10
mL), placed on an alumina column, and equilibrated with light
petroleum. The desired products were collected as orange
eluates and concentrated to a small volume (about 1 mL). By
adding petroleum ether 40-60 (about 30 mL), bimetallic
complexes precipitated as orange powders. Yields were higher
than 80%.
3
9A); 190.4 (d, J C-P ) 10, 0.5C, CS trans to P 9B); 190.1 (d,
3J C-P ) 3, 0.5C, CS cis to P 9A); 189.8 (d, J C-P)3, 0.5C, CS
3
cis to P 9A); 150.0-125.0 (29C, ArC and pyrC); 60.5 (1C,
NCHPh cis to P overlapped 9A a n d 9B); 59.9 (1C, NCHPh
trans to P overlapped 9A a n d 9B); 111.9 (1C, central-allyl CH);
58.7 (1C, allyl CH2 cis to P overlapped 9A a n d 9B); 57.9 (1C,
allyl CH2 trans to P overlapped 9A a n d 9B); 18.5 (0.5C, CH3
cis to P, 9A); 17.4 (0.5C, CH3 cis to P 9B); 18.3 (0.5C, CH3
trans to P 9A); 17.2 (0.5C, CH3 trans to P 9B). 31P{1H} NMR
1
(121.49 MHz, CDCl3, 298 K): 17.5 (0.5P, J Pt-P ) 3273, Pt-
1
P); 17.4 (0.5P, J Pt-P ) 3273, Pt-P). Anal (%) Calcd for
C
38H37N3PS2ClPdPt: C, 46.20; H, 3.86; N, 4.35; S, 6.62; Cl,
3.62. Found: C, 46.42; H, 3.71; N, 4.21; S, 6.56; Cl, 3.41.
X-r a y Cr ysta llogr a p h ic Stu d ies of 8. Diffraction data of
a suitable crystal were collected at room temperature on a
Siemens P4 automatic four-circle diffractometer by using
graphite-monochromated Mo KR radiation. Lattice parameters
were obtained from least-squares refinement of the setting
angles of 35 reflections with 11° e 2θ e 30°. No sign of crystal
deterioration was revealed during the data collection. The
[(P N)ClP t(µ-N,N′-(C2H5)2N2S2C2-K-S,S′-P tK-N,N′-P d )(η3-
a llyl)P d ] (7). 1H NMR (300.13 MHz, CDCl3, 298 K): 8.68 (m,
1H, pyr H-6); 8.47(m, 1H, pyrH-3); 7.80÷7.13, (12 H, ArH and
2
3
pyrH); 5.39 (m, 1H, allyl CH); 4.81 (dq, J H-H ) 13.8, J H-H
)
)
2
6.8, 2H, NCH2 cis to P, part AB of ABC3); 3.38 (dq, J H-H